Retraction: Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy
- PMID: 38408063
- PMCID: PMC10896498
- DOI: 10.1371/journal.pone.0299822
Retraction: Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy
Retraction of
-
Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy.PLoS One. 2013;8(2):e55790. doi: 10.1371/journal.pone.0055790. Epub 2013 Feb 7. PLoS One. 2013. Retraction in: PLoS One. 2024 Feb 26;19(2):e0299822. doi: 10.1371/journal.pone.0299822. PMID: 23409045 Free PMC article. Retracted.
References
Publication types
LinkOut - more resources
Full Text Sources
